Date published: 2026-8-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

T1R2 CRISPR/Cas9 KO Plasmid (h): sc-402555

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • T1R2 CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
  • gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the T1R2 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
  • The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    T1R2 CRISPR/Cas9 KO Plasmid (h)

    sc-402555
    20 µg
    $397.00

    Overview

    TAS1R2 encodes the sweet taste receptor subunit T1R2, a class C GPCR that heterodimerizes with T1R3 to detect sugars and sweeteners and couple ligand binding to intracellular second-messenger signaling. Beyond gustatory cells, T1R2/T1R3 signaling has been reported in enteroendocrine and other chemosensory contexts where it can influence nutrient sensing and downstream hormone or metabolic responses. Receptor activation is commonly linked to GPCR-mediated pathways involving G proteins, PLCβ2, intracellular Ca²⁺ mobilization, and downstream MAPK or transcriptional programs depending on cell type. Altered TAS1R2 expression or variants have been investigated in relation to metabolic phenotypes, dietary behavior, and glucose homeostasis, supporting its relevance for studies of nutrient-responsive signaling networks.

    T1R2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the TAS1R2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the TAS1R2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.

    The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the TAS1R2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish T1R2 protein expression.

    This CRISPR knockout system enables efficient generation of TAS1R2-deficient cell models for investigation of T1R2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.

    Key Features

    • sgRNAs targeting TAS1R2 exon(s) critical for T1R2 function
    • Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
    • GFP reporter for identification of transfected cells
    • Pool of plasmids targeting multiple TAS1R2 genomic sites to improve knockout efficiency
    • Compatible with delivery by transfection

    Design Variants

    CRISPRs +/- HDRs

    • gRNAs encoded by T1R2 CRISPR/Cas9 KO Plasmid (h) and T1R2 CRISPR/Cas9 KO Plasmid (h2) target distinct sites within the TAS1R2 locus. One or both targeting designs may be available. See Related Products for availability.
    • HDR donor constructs encoded by T1R2 HDR Plasmid (h) and T1R2 HDR Plasmid (h2) contain a puromycin resistance cassette and an RFP reporter flanked by TAS1R2 homology arms to support homology-directed repair at defined TAS1R2 target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.